VBI Vaccines Picks 2 Coronavirus Vaccine Candidates for Further Development

VBI Vaccines (NASDAQ: VBIV) was a stock market star on Thursday, following some positive news items about its development of a coronavirus vacicine...or vaccines.

The company said it has chosen two vaccine candidates for further development. Both VBI-2901 and VBI-2902 have the potential to be one-dose vaccines, which is attention-grabbing as some of the more advanced candidates being developed by rivals require two doses.

Image source: Getty Images.

Continue reading

Source Fool.com